• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经蝶窦内镜垂体手术优于经鼻中隔显微镜垂体手术治疗库欣病。

Superiority of endoscopic transsphenoidal pituitary surgery to microscopic transseptal pituitary surgery for treatment of Cushing's disease.

机构信息

PLA Rocket Force Characteristic Medical Center, Department of Neurosurgery - Beijing, China.

出版信息

Rev Assoc Med Bras (1992). 2021 Nov;67(11):1687-1691. doi: 10.1590/1806-9282.20210732.

DOI:10.1590/1806-9282.20210732
PMID:34909899
Abstract

OBJECTIVE

This study aims to compare the efficacy and safety of endoscopic transsphenoidal pituitary surgery and microscopic transseptal pituitary surgery in the treatment of Cushing's disease (CD).

METHODS

A total of 46 patients with CD were randomized into endoscopic group and microscopic group, with 23 cases in each group. The endoscopic group received the endoscopic transsphenoidal pituitary surgery, and the microscopic group received the microscopic transseptal pituitary surgery. The retrospective data, surgical outcomes, surgical cure rates, and complications in two groups were compared.

RESULTS

Compared with microscopic group, the operative time was significantly shorter (p<0.05), the estimated blood loss was significantly less (p<0.05), and the hospital stay was significantly shorter (p<0.05) in endoscopic group. The surgical cure rate in endoscopic and microscopic groups was 69.56% and 60.86%, respectively, with no significant difference between the two groups (p>0.05). The incidence of complications in endoscopic group was significantly lower than that in microscopic group (p<0.01).

CONCLUSIONS

For the treatment of CD, the efficacy of endoscopic transsphenoidal pituitary surgery is basically the same as that of traditional microscopic transseptal pituitary surgery. However, the endoscopic surgery can further shorten the operative time, reduce the estimated blood loss, shorten the hospital stay, and reduce the complications.

摘要

目的

本研究旨在比较内镜经鼻蝶窦垂体手术和显微镜经鼻中隔垂体手术治疗库欣病(CD)的疗效和安全性。

方法

将 46 例 CD 患者随机分为内镜组和显微镜组,每组 23 例。内镜组行内镜经鼻蝶窦垂体手术,显微镜组行显微镜经鼻中隔垂体手术。比较两组患者的回顾性资料、手术结果、手术治愈率和并发症。

结果

与显微镜组相比,内镜组的手术时间明显缩短(p<0.05),估计出血量明显减少(p<0.05),住院时间明显缩短(p<0.05)。内镜组和显微镜组的手术治愈率分别为 69.56%和 60.86%,两组间差异无统计学意义(p>0.05)。内镜组并发症发生率明显低于显微镜组(p<0.01)。

结论

对于 CD 的治疗,内镜经鼻蝶窦垂体手术的疗效基本与传统显微镜经鼻中隔垂体手术相同。然而,内镜手术可以进一步缩短手术时间,减少估计出血量,缩短住院时间,减少并发症。

相似文献

1
Superiority of endoscopic transsphenoidal pituitary surgery to microscopic transseptal pituitary surgery for treatment of Cushing's disease.经蝶窦内镜垂体手术优于经鼻中隔显微镜垂体手术治疗库欣病。
Rev Assoc Med Bras (1992). 2021 Nov;67(11):1687-1691. doi: 10.1590/1806-9282.20210732.
2
Long-Term Outcomes and Complications from Endoscopic Versus Microscopic Transsphenoidal Surgery for Cushing's Disease: A 15-Year Single-Center Study.内镜经蝶窦与显微镜经蝶窦手术治疗库欣病的长期疗效和并发症:一项 15 年单中心研究。
World Neurosurg. 2022 Oct;166:e427-e434. doi: 10.1016/j.wneu.2022.07.027. Epub 2022 Jul 12.
3
Management of Cushing's Disease: Changing Trend from Microscopic to Endoscopic Surgery.库欣病的治疗:从显微镜手术到内镜手术的变化趋势。
World Neurosurg. 2020 Feb;134:e46-e54. doi: 10.1016/j.wneu.2019.08.165. Epub 2019 Sep 3.
4
Exoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a retrospective single-center study on 388 patients.经蝶窦手术治疗库欣病:一项回顾性单中心 388 例患者研究
Neurosurg Rev. 2022 Dec;45(6):3675-3681. doi: 10.1007/s10143-022-01866-5. Epub 2022 Sep 22.
5
Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing's disease: surgical outcome, mortality, and complications.显微镜下经蝶窦手术与内镜下经蝶窦手术治疗库欣病的莱顿队列研究:手术结果、死亡率和并发症。
Orphanet J Rare Dis. 2019 Mar 11;14(1):64. doi: 10.1186/s13023-019-1038-0.
6
Endoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis.内镜经鼻蝶窦与显微镜经鼻蝶窦手术治疗库欣病的系统评价和荟萃分析。
Pituitary. 2018 Oct;21(5):524-534. doi: 10.1007/s11102-018-0893-3.
7
Analysis of transnasal endoscopic versus transseptal microscopic approach for excision of pituitary tumors.经鼻内镜与经鼻中隔显微镜入路切除垂体瘤的分析
Am J Rhinol. 2008 Nov-Dec;22(6):649-52. doi: 10.2500/ajr.2008.22.3246.
8
Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease.鼻内镜经蝶窦垂体手术:小儿库欣病的早期经验与结果
Clin Endocrinol (Oxf). 2014 Feb;80(2):270-6. doi: 10.1111/cen.12275. Epub 2013 Jul 19.
9
Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.经验较少的外科医生采用完全内镜技术与经验非常丰富的外科医生采用显微镜下经蝶窦技术治疗垂体腺瘤的疗效比较。
J Neurosurg. 2016 Mar;124(3):596-604. doi: 10.3171/2015.4.JNS15102. Epub 2015 Oct 16.
10
Intraoperative conversion from endoscopic to microscopic approach for the management of sellar pathology: incidence and rationale in a contemporary series.经内镜入路至显微镜入路在鞍区病变治疗中的术中转换:当代系列中的发生率和原理。
World Neurosurg. 2010 Apr;73(4):334-7. doi: 10.1016/j.wneu.2010.02.069.

引用本文的文献

1
Navigating the Surgical Landscape: A Comprehensive Analysis of Endoscopic vs. Microscopic Transsphenoidal Pituitary Surgery Outcomes.探索手术领域:内镜与显微镜下经蝶窦垂体手术结果的综合分析
Cureus. 2024 Feb 5;16(2):e53633. doi: 10.7759/cureus.53633. eCollection 2024 Feb.
2
Comparison of microscopic transsphenoidal surgery and neuroendoscopic transsphenoidal surgery in pituitary adenoma resection and the risk factors of postoperative cerebrospinal fluid leakage.显微镜下经蝶窦手术与神经内镜下经蝶窦手术在垂体腺瘤切除术中的比较及术后脑脊液漏的危险因素
Am J Transl Res. 2023 Jul 15;15(7):4746-4754. eCollection 2023.
3
An individualized approach to the management of Cushing disease.
个体化治疗库欣病的方法。
Nat Rev Endocrinol. 2023 Oct;19(10):581-599. doi: 10.1038/s41574-023-00868-7. Epub 2023 Aug 3.
4
Cushing's Disease Management: Glimpse Into 2051.库欣病管理:展望 2051 年。
Front Endocrinol (Lausanne). 2022 Jul 6;13:943993. doi: 10.3389/fendo.2022.943993. eCollection 2022.